iX Biopharma Ratios and Metrics

Market cap in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	192	14	22	70	122	167
Market Cap Growth	735.51%	-36.24%	-68.05%	-43.05%	-26.84%	3.17%
Enterprise Value	197	17	22	62	111	162
PS Ratio	24.71	1.83	3.74	11.79	8.51	95.91
PB Ratio	525.72	38.92	5.13	4.40	6.20	14.29
P/TBV Ratio	2019.88	149.55	5.51	4.48	6.31	14.81
P/FCF Ratio	-	-	-	-	41.89	-
P/OCF Ratio	-	-	-	-	39.21	-
EV/Sales Ratio	25.35	2.20	3.73	10.51	7.70	92.74
EV/EBITDA Ratio	-	-	-	-	96.40	-
EV/EBIT Ratio	-	-	-	-	221.09	-
EV/FCF Ratio	-49.72	-	-	-	37.89	-
Debt / Equity Ratio	16.17	16.17	1.20	0.27	0.22	0.36
Debt / EBITDA Ratio	-	-	-	-	2.91	-
Debt / FCF Ratio	-	-	-	-	1.51	-
Asset Turnover	0.60	0.60	0.30	0.22	0.61	0.10
Inventory Turnover	4.98	4.98	4.21	3.86	2.09	2.14
Quick Ratio	0.32	0.32	0.65	1.34	1.98	2.19
Current Ratio	0.47	0.47	0.89	1.53	2.14	2.55
Return on Equity (ROE)	-431.07%	-431.07%	-106.91%	-54.02%	-29.23%	-75.27%
Return on Assets (ROA)	-30.32%	-30.32%	-23.69%	-22.32%	1.32%	-39.86%
Return on Capital Employed (ROCE)	-272.70%	-272.70%	-103.50%	-53.80%	2.40%	-75.20%
Earnings Yield	-5.28%	-71.38%	-48.44%	-13.79%	-3.75%	-4.92%
FCF Yield	-2.06%	-27.87%	-30.64%	-11.98%	2.39%	-5.32%
Buyback Yield / Dilution	-14.25%	-14.25%	-0.33%	-2.51%	-7.60%	-7.13%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.